Cabaletta Bio is trading at $1.44, down -5.59%, with no clear company-specific explanation surfaced for the October 23 decline.
- The company’s latest located press release was dated October 5 and concerned inducement equity awards.
- The Dow was down 1.11%, the S&P 500 down 0.42%, and Nasdaq down 0.01%; these figures do not establish a broader-market cause for the stock’s move.
- No trading-volume data was provided, so activity level cannot be assessed.